---
title: Publications
layout: page
---

A full list of publications can be found [here](https://scholar.google.lu/citations?user=JFRauOgAAAAJ&hl=en).

#Key research papers

Histological Transformation and Progression in Follicular Lymphoma: a Clonal Evolution Study. Kridel R\*, Chan FC\*, Mottok A, Boyle M, Farinha P, Tan K, Meissner B, Bashashati A, McPherson A, Roth A, Shumansky K, Yap D, Ben-Neriah S, Rosner J, Smith MA, Nielsen C, Giné E, Telenius A, Ennishi D, Mungall A, Moore R, Morin RD, Johnson NA, Sehn LH, Tousseyn T, Dogan A, Connors JM, Scott DW, Steidl C, Marra MA, Gascoyne RD, Shah P. PLOS Medicine. 2016 Dec 13;13(12):e1002197. (\* denotes equal contribution)

Diffuse large B-cell lymphoma with testicular involvement: Outcome and risk of CNS relapse in the rituximab era. Kridel R\*, Telio D\*, Villa D, Sehn LH, Gerrie A, Shenkier T, Klasa R, Slack GW, Tan K, Gascoyne RD, Connors JM and Savage KJ. British Journal of Haematology. 2016 Oct 14. doi: 10.1111/bjh.14392. [Epub ahead of print] (\* denotes equal contribution)

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy. Jurinovic V, Kridel R, Staiger AM, Szczepanowski M, Horn H, Dreyling MH, Rosenwald A, Ott G, Klapper W, Zelenetz AD, Barr PM, Friedberg JW, Ansell S, Sehn LH, Connors JM, Gascoyne RD, Hiddemann W, Unterhalt M, Weinstock DM, Weigert O. Blood. 2016 Aug 25;128(8):1112-20.

Cell of origin of transformed follicular lymphoma. Kridel R,\* Mottok A,\* Farinha P, Ben-Neriah S, Ennishi D, Zheng Y, Chavez EA, Shulha HP, Tan K, Chan FC, Boyle M, Meissner B, Telenius A, Sehn LH, Marra AM, Shah SP, Steidl S, Connors JM, Scott DW, Gascoyne RD. Blood 2015 Oct 29;126(18):2118-27. (\* denotes equal contribution)

Integration of Gene Mutations Improves Risk Prognostication in Patients Receiving First-line Immunochemotherapy for Follicular Lymphoma in Clinical Trial and Population-Based Cohorts. Pastore A,\* Jurinovic V,\* Kridel R,\* Hoster E,\* Staiger AM, Sczcepanowski M, Pott C, Kopp N, Murakami M, Horn H, Leich E, Moccia AA, Mottok A, Sunkavalli A, Van Hummelen P, Ducar M, Ennishi D, Shulha HP, Hother C, Connors JM, Sehn LH, Dreyling M, Neuberg D, Möller P, Feller AC, Hansmann, ML, Stein H, Rosenwald A, Ott G, Klapper W, Unterhalt M, Hiddemann W, Gascoyne RD, Weinstock DM, Weigert O. Lancet Oncol. 2015 Sep;16(9):1111-22. (\* denotes equal contribution)

The prognostic impact of CD163-positive macrophages in follicular lymphoma: A study from the BC Cancer Agency and the LYmphoma Study Association. Kridel R, Xerri L, Gelas-Dore B, Tan K, Feugier P, Vawda A, Canioni D, Farinha P, Boussetta S, Moccia AA, Brice P, Chavez EA, Kyle AH, Scott DW, Sanders AD, Fabiani B, Slack GW, Minchinton AI, Haioun C, Connors JM, Sehn LH, Steidl C, Gascoyne RD, Salles G. Clin Cancer Res. 2015 Aug 1;21(15):3428-35.

Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Kridel R, Meissner B, Rogic S, Boyle M, Telenius A, Woolcock B, Gunawardana J, Jenkins C, Cochrane C, Ben-Neriah S, Tan K, Morin RD, Opat S, Sehn LH, Connors JM, Marra MA, Weng AP, Steidl C, Gascoyne RD. Plenary Paper. Blood. 2012 Mar 1;119(9):1963-71.

#Key review papers

Pathogenesis of follicular lymphoma. Kridel R, Sehn LH, Gascoyne RD. J Clin Invest. 2012 Oct 1;122(10):3424-31.

Prevention of Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma. Kridel R, Dietrich PY. Lancet Oncol. 2011 Dec;12(13):1258-66.
